Remove topics advisory-committee
article thumbnail

What is the Trademark Public Advisory Committee (TPAC)?

Erik K Pelton

The following is an edited transcript of my video What is the Trademark Public Advisory Committee (TPAC)? The Trademark Public Advisory Committee (TPAC) is a public committee commissioned by the USPTO that helps advise and give feedback on important issues. What are the backlogs?

Trademark 147
article thumbnail

This Week in Washington IP: Securing U.S. Leadership in Emerging Compute Technologies, Managing the Risks of AI, and Incorporating Commercial Drones Into U.S. Airspace

IP Watchdog

national airspace, while the full Senate Commerce Committee explores how to maintain U.S. Over in the House of Representatives, the House Science Committee focuses on the risks that must be managed as artificial intelligence (AI) systems become more highly developed. leadership in emerging compute technologies. Elsewhere, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

This Week in Washington IP: Cybersecurity in Civil Space Operations, Coordinating Patent Data Between the USPTO and the FDA, and Innovative Ideas for Modernizing Congress

IP Watchdog

This week in Washington IP news, committee hearings at the U.S. House of Representatives focus on several topics related to technology including improvements to civil space procurement activities to promote cybersecurity in space systems, the use of facial recognition technology by U.S. Patent and Trademark Office and the U.S.

IP 105
article thumbnail

Trademark Fee Proposal Comments by EMP&A Focus on Impact on Small Businesses and USPTO IT Expenditures

Erik K Pelton

Last week, Erik provided comments to the USPTO’s Trademark Public Advisory Committee regarding proposed changes (increases) to many trademark fees. Pelton & Associates, PLLC Regarding “Trademark Public Advisory Committee Public Hearing on the Proposed Trademark Fee Schedule” The following are comments provided by Erik M.

Business 130
article thumbnail

Bayh Dole-esque Guidelines Notified by Dept of Biotechnology

SpicyIP

It’s unclear where the mandate is coming from, as guidelines generally do not have the power of law behind them but are merely discretionary / advisory). All Indian Patents are certainly not secured by the GoI through March-in Rights, and as we saw during Covid , there was little to no inclination to bring the topic up at all.

article thumbnail

Strategic Moves: Navigating Mergers & Acquisitions Seminar

LexBlog IP

She is also a member of the firm’s Executive Committee. She’s a principal and chair of the Tax Advisory Group at HBK CPAs & Consultants. Matthew Brust handles all aspects of business formations, operations, taxation (both state and federal), with a strong focus on mergers and acquisitions.

article thumbnail

FDA Testimony Before the U.S. Senate Regarding Reauthorization of the Biosimilar User Fee Act

LexBlog IP

This week Patrizia Cavazzoni (Director, CDER), Peter Marks (Director, CBER), and Jeffrey Shuren (Director, CDRH) of the FDA testified before the committee on Health Education, Labor and Pensions of the U.S. The testimony spanned many topics, but notably the FDA discussed the progress of biosimilar approvals, including its impact on cost.